L. Joseph Wheat, M.D., founded MiraVista Diagnostics and MiraBella Technologies in 2002. The name MiraVista Diagnostics takes its inspiration from Dr. Wheat’s granddaughter, MiraBella. It is also the namesake for MiraVista Diagnostics’ sister company, aptly named MiraBella Technologies, which focuses on new research.A Note from Dr. WheatFor the past 20 years, I have dedicated myself to the improvement of fungal diagnostics. My research yielded the Histoplasma antigen assay, and more recently the Blastomyces antigen test. Through continuing research and education, I am committed to providing the kind of innovative, relevant technological advances that improve all of our lives.Please take the opportunity to explore our site. And let us know how we’ve done in gathering and presenting the kind of information you rely upon.
Sincerely,
L. Joseph Wheat, M.D.
President and Director
MiraVista Diagnostics
MiraVista Diagnostics & MiraBella Technologies
MiraVista Diagnostics was formed to provide Histoplasma antigen testing to customers throughout the United States. Since the company’s inception, additional tests have been incorporated into our menu of services. MiraBella Technologies provides clinical research for our organization. This research is focused on the development of high-complexity tests targeted for use at large referral laboratories.
History
L. Joseph Wheat, M.D. founded MiraVista Diagnostics and MiraBella Technologies in 2002. Both organizations focus on developing improved fungal diagnostic testing. For over two decades, Dr. Wheat served as a Professor of Medicine and Pathology at Indiana University School of Medicine, Indianapolis, where his research yielded the Histoplasma antigen test. With MiraVista Diagnostics and MiraBella Technologies, Dr. Wheat continues to focus on the development of high-complexity tests coupled with same-day referral testing.
Vision
Our vision is to produce new tests in compliance with quality standards and to attain FDA clearance to distribute these tests to reference laboratories. To realize this vision, we have assembled highly specialized personnel, established a technology-driven environment, and made the commitment to seek FDA clearance of products that are appropriate for incorporation into large referral laboratory testing. At the same time, we continue to provide high quality, same-day testing services at MiraVista Diagnostics.
Description
MiraVista Diagnostics. MiraVista Diagnostics was formed to provide Histoplasma antigen testing to customers throughout the United States. Since the company’s inception, additional tests have been incorporated into our menu of services. New rapid tests developed by MiraBella Technologies or selected tests available commercially will be added to our referral services. MiraVista also serves as the US agent for Statens Serum Institut (Copenhagen, DK), handling sales and distribution of their products in the US.
MiraBella Technologies. MiraBella Technologies conducts research to develop new tests for rapid diagnosis of infectious diseases.